FGEN Competitors & Alternatives
Compare FibroGen Inc with similar stocks in the same industry
Biotechnology
FGEN
Main Stock$9.71
Tradestie Score
43
Market Cap
$48.63M
Revenue Growth
7.7%
Analyst Upside
+342.8%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$14.25
|
$133.50M | - | 41 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.20
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$32.00
|
$110.20M | - | 48 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$6.04
|
$107.83M | - | 38 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 49 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.22
|
$71.32M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.14
|
$67.94M | - | 42 | Compare |
|
TPIC
TPIC
|
- | - | - | - | Compare |
|
AFMD
AFMD
|
- | - | - | - | Compare |
|
MEIP
MEIP
|
- | - | - | 49 | Compare |
More FGEN Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry